These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10683014)

  • 61. Toxicity of antiretroviral therapy and implications for drug development.
    Carr A
    Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812
    [No Abstract]   [Full Text] [Related]  

  • 62. Immune recovery inflammatory folliculitis.
    Bouscarat F; Maubec E; Matheron S; Descamps V
    AIDS; 2000 Mar; 14(5):617-8. PubMed ID: 10780726
    [No Abstract]   [Full Text] [Related]  

  • 63. New dilemmas as patients live longer and side effects take hold.
    Carney L; Dugas AA
    HIV Clin; 2004; 16(4):6-7, 9. PubMed ID: 15595163
    [No Abstract]   [Full Text] [Related]  

  • 64. Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system.
    Gabuzda D; McArthur JC; Letendre SL
    AIDS; 2020 Nov; 34(13):1975-1977. PubMed ID: 33009012
    [No Abstract]   [Full Text] [Related]  

  • 65. Lenacapavir: an attractive option, but proceed with caution.
    Harris M
    Lancet HIV; 2023 Aug; 10(8):e486-e487. PubMed ID: 37451298
    [No Abstract]   [Full Text] [Related]  

  • 66. Lenacapavir.
    Beninger P
    Clin Ther; 2024 Feb; 46(2):183-184. PubMed ID: 38326158
    [No Abstract]   [Full Text] [Related]  

  • 67. Inflammation: Immune recovery drives bone loss.
    Holmes D
    Nat Rev Endocrinol; 2015 Dec; 11(12):689. PubMed ID: 26460343
    [No Abstract]   [Full Text] [Related]  

  • 68. Lenacapavir (Sunlenca®) for the treatment of HIV-1.
    Patel PC; Beasley HK; Hinton A; Wanjalla CN
    Trends Pharmacol Sci; 2023 Aug; 44(8):553-554. PubMed ID: 37330326
    [No Abstract]   [Full Text] [Related]  

  • 69. When Patients Tell a Story We Have Not Yet Learned to Hear.
    Hibbs S
    Hemasphere; 2023 Apr; 7(4):e859. PubMed ID: 36891456
    [No Abstract]   [Full Text] [Related]  

  • 70. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

  • 71. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 72. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 73. New HIV drugs show promise in early studies.
    McCarthy M
    Lancet; 2002 Mar; 359(9308):767. PubMed ID: 11888592
    [No Abstract]   [Full Text] [Related]  

  • 74. [HIV and antiretroviral therapy: in every 3rd patient a virus rebound takes place].
    Kunde K
    Dtsch Med Wochenschr; 2000 Aug; 125(33):A10. PubMed ID: 11023348
    [No Abstract]   [Full Text] [Related]  

  • 75. Experts hear sobering side of HIV-1 treatment story.
    Morris K
    Lancet; 2000 Feb; 355(9203):555. PubMed ID: 10683014
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.